Cargando…

Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients

Adaptive natural killer (NK) cell responses to human cytomegalovirus infection are characterized by the expansion of NKG2C(+) NK cells expressing self-specific inhibitory killer-cell immunoglobulin-like receptors (KIRs). Here, we set out to study the HLA class I dependency of such NKG2C(+) NK cell e...

Descripción completa

Detalles Bibliográficos
Autores principales: Béziat, Vivien, Sleiman, Marwan, Goodridge, Jodie P., Kaarbø, Mari, Liu, Lisa L., Rollag, Halvor, Ljunggren, Hans-Gustaf, Zimmer, Jacques, Malmberg, Karl-Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594010/
https://www.ncbi.nlm.nih.gov/pubmed/26500647
http://dx.doi.org/10.3389/fimmu.2015.00507
_version_ 1782393394266374144
author Béziat, Vivien
Sleiman, Marwan
Goodridge, Jodie P.
Kaarbø, Mari
Liu, Lisa L.
Rollag, Halvor
Ljunggren, Hans-Gustaf
Zimmer, Jacques
Malmberg, Karl-Johan
author_facet Béziat, Vivien
Sleiman, Marwan
Goodridge, Jodie P.
Kaarbø, Mari
Liu, Lisa L.
Rollag, Halvor
Ljunggren, Hans-Gustaf
Zimmer, Jacques
Malmberg, Karl-Johan
author_sort Béziat, Vivien
collection PubMed
description Adaptive natural killer (NK) cell responses to human cytomegalovirus infection are characterized by the expansion of NKG2C(+) NK cells expressing self-specific inhibitory killer-cell immunoglobulin-like receptors (KIRs). Here, we set out to study the HLA class I dependency of such NKG2C(+) NK cell expansions. We demonstrate the expansion of NKG2C(+) NK cells in patients with transporter associated with antigen presentation (TAP) deficiency, who express less than 10% of normal HLA class I levels. In contrast to normal individuals, expanded NKG2C(+) NK cell populations in TAP-deficient patients display a polyclonal KIR profile and remain hyporesponsive to HLA class I-negative target cells. Nonetheless, agonistic stimulation of NKG2C on NK cells from TAP-deficient patients yielded significant responses in terms of degranulation and cytokine production. Thus, while interactions with self-HLA class I molecules likely shape the KIR repertoire of expanding NKG2C(+) NK cells during adaptive NK cell responses in normal individuals, they are not a prerequisite for NKG2C(+) NK cell expansions to occur. The emergence of NKG2C-responsive adaptive NK cells in TAP-deficient patients may contribute to antiviral immunity and potentially explain these patients’ low incidence of severe viral infections.
format Online
Article
Text
id pubmed-4594010
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-45940102015-10-23 Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients Béziat, Vivien Sleiman, Marwan Goodridge, Jodie P. Kaarbø, Mari Liu, Lisa L. Rollag, Halvor Ljunggren, Hans-Gustaf Zimmer, Jacques Malmberg, Karl-Johan Front Immunol Immunology Adaptive natural killer (NK) cell responses to human cytomegalovirus infection are characterized by the expansion of NKG2C(+) NK cells expressing self-specific inhibitory killer-cell immunoglobulin-like receptors (KIRs). Here, we set out to study the HLA class I dependency of such NKG2C(+) NK cell expansions. We demonstrate the expansion of NKG2C(+) NK cells in patients with transporter associated with antigen presentation (TAP) deficiency, who express less than 10% of normal HLA class I levels. In contrast to normal individuals, expanded NKG2C(+) NK cell populations in TAP-deficient patients display a polyclonal KIR profile and remain hyporesponsive to HLA class I-negative target cells. Nonetheless, agonistic stimulation of NKG2C on NK cells from TAP-deficient patients yielded significant responses in terms of degranulation and cytokine production. Thus, while interactions with self-HLA class I molecules likely shape the KIR repertoire of expanding NKG2C(+) NK cells during adaptive NK cell responses in normal individuals, they are not a prerequisite for NKG2C(+) NK cell expansions to occur. The emergence of NKG2C-responsive adaptive NK cells in TAP-deficient patients may contribute to antiviral immunity and potentially explain these patients’ low incidence of severe viral infections. Frontiers Media S.A. 2015-10-06 /pmc/articles/PMC4594010/ /pubmed/26500647 http://dx.doi.org/10.3389/fimmu.2015.00507 Text en Copyright © 2015 Béziat, Sleiman, Goodridge, Kaarbø, Liu, Rollag, Ljunggren, Zimmer and Malmberg. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Béziat, Vivien
Sleiman, Marwan
Goodridge, Jodie P.
Kaarbø, Mari
Liu, Lisa L.
Rollag, Halvor
Ljunggren, Hans-Gustaf
Zimmer, Jacques
Malmberg, Karl-Johan
Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients
title Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients
title_full Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients
title_fullStr Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients
title_full_unstemmed Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients
title_short Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients
title_sort polyclonal expansion of nkg2c(+) nk cells in tap-deficient patients
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594010/
https://www.ncbi.nlm.nih.gov/pubmed/26500647
http://dx.doi.org/10.3389/fimmu.2015.00507
work_keys_str_mv AT beziatvivien polyclonalexpansionofnkg2cnkcellsintapdeficientpatients
AT sleimanmarwan polyclonalexpansionofnkg2cnkcellsintapdeficientpatients
AT goodridgejodiep polyclonalexpansionofnkg2cnkcellsintapdeficientpatients
AT kaarbømari polyclonalexpansionofnkg2cnkcellsintapdeficientpatients
AT liulisal polyclonalexpansionofnkg2cnkcellsintapdeficientpatients
AT rollaghalvor polyclonalexpansionofnkg2cnkcellsintapdeficientpatients
AT ljunggrenhansgustaf polyclonalexpansionofnkg2cnkcellsintapdeficientpatients
AT zimmerjacques polyclonalexpansionofnkg2cnkcellsintapdeficientpatients
AT malmbergkarljohan polyclonalexpansionofnkg2cnkcellsintapdeficientpatients